Crossmark

Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials

Published Online: 2021-09-13

Authors

Sabe, Michel https://orcid.org/0000-0002-8530-5596
Zhao, Nan

Crippa, Alessio

Kaiser, Stefan https://orcid.org/0000-0002-3013-2034
License Information

Text and Data Mining valid from 2021-09-13

Version of Record valid from 2021-09-13
More Information

Article History

Received: 20 March 2021

Accepted: 6 August 2021

First Online: 13 September 2021

Competing interests

: S.K. has received royalties for cognitive test and training software from Schufried. M.S., N.Z. and A.C. report no competing interests.

Document is current